Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.5706
Delayed Data
As of Sep 23
 -0.0132 / -2.26%
Today’s Change
0.55
Today|||52-Week Range
3.66
-78.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$55.3M

Company Description

CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It provides clinical development of aldoxorubicin oncology pipeline for the treatment of cancer. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Contact Information

CytRx Corp.
11726 San Vicente Boulevard
Los Angeles California 90049
P:(310) 826-5648
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Steven A. KriegsmanChairman, President & Chief Executive Officer
John Y. CalozChief Financial Officer & Treasurer
Daniel J. LevittChief Medical Officer & Executive Vice President
Douglas Scott WielandSenior Vice President-Drug Development
Shanta P. ChawlaVice President-Clinical Development